The store will not work correctly when cookies are disabled.
N-(2-chloro-5-(trifluoromethyl)phenyl)quinoline-8-sulfonamide
ID: ALA4857014
PubChem CID: 1035407
Max Phase: Preclinical
Molecular Formula: C16H10ClF3N2O2S
Molecular Weight: 386.78
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1cc(C(F)(F)F)ccc1Cl)c1cccc2cccnc12
Standard InChI: InChI=1S/C16H10ClF3N2O2S/c17-12-7-6-11(16(18,19)20)9-13(12)22-25(23,24)14-5-1-3-10-4-2-8-21-15(10)14/h1-9,22H
Standard InChI Key: BGSLYCUFUUYMEC-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
38.2240 -15.0795 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.0113 -15.8801 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
38.8111 -15.6640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.4283 -16.5974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2540 -16.5974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6650 -17.3148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4900 -17.3151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9036 -16.5995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4863 -15.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6627 -15.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8967 -15.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1898 -15.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7799 -15.1668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9549 -15.1665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5413 -15.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7822 -16.5963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9625 -16.5979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5558 -17.3074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9677 -18.0158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7905 -18.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1934 -17.3001 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2508 -18.0291 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
41.7224 -15.1626 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.4813 -14.4519 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
41.3016 -14.4455 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
4 2 1 0
2 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 17 1 0
16 12 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 16 2 0
6 22 1 0
11 23 1 0
11 24 1 0
11 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 386.78 | Molecular Weight (Monoisotopic): 386.0104 | AlogP: 4.71 | #Rotatable Bonds: 3 |
Polar Surface Area: 59.06 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.14 | CX Basic pKa: 0.47 | CX LogP: 4.10 | CX LogD: 4.04 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.71 | Np Likeness Score: -2.19 |
References
1. Richardson NL, O'Malley LJ, Weissberger D, Tumber A, Schofield CJ, Griffith R, Jones NM, Hunter L.. (2021) Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2., 38 [PMID:33862469] [10.1016/j.bmc.2021.116115] |